Antineutrophil cytoplasmic antibody-associated vasculitis

Clinical trials for Antineutrophil cytoplasmic antibody-associated vasculitis explained in plain language.

Never miss a new study

Get alerted when new Antineutrophil cytoplasmic antibody-associated vasculitis trials appear

Sign up with your email to follow new studies for Antineutrophil cytoplasmic antibody-associated vasculitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet finished but already full! 1

Could CAR t cells tame vasculitis? early trial aims to find out

Disease control Ongoing

This early-phase trial is testing a new treatment called CC-97540, a type of CAR T cell therapy, in 12 people with severe ANCA-associated vasculitis that has not responded to standard treatments. The therapy is designed to target and destroy certain immune cells that drive the di…

Matched conditions: ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS

Phase 1/2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

Antineutrophil cytoplasmic antibody-associated vasculitis

Get alerted when new Antineutrophil cytoplasmic antibody-associated vasculitis trials appear

Could CAR t cells tame vasculitis? early trial aims to find out